Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion type Assertion NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_head.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion description "[P-cadherin, Vimentin and CK14 can recognize BLBC already identified in triple negative/ CK5 and/or EGFR+ tumors, and due to P-cadherin sensitivity for BLBC identification this marker can reliably recruit a large number of breast carcinomas with basal phenotype among immunohistochemistry triple negative/ CK5 and/or EGFR - pool of tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_provenance.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion evidence source_evidence_literature NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_provenance.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion SIO_000772 20552547 NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_provenance.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion wasDerivedFrom befree-2016 NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_provenance.
- NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_assertion wasGeneratedBy ECO_0000203 NP819218.RAdBRWe0YHeNzjpsELFG4G5rF7Ji9UWK0AgyAeGLgEGQI130_provenance.